The pharmaceutical industry is bracing for a severe hit to investments with the Senate passage of a bill that would give Medicare the authority to set price caps on some expensive prescription drugs.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.